We have identified a chromosome 4p haplotype which segregates with L-dopa responsive, Lewy body parkinsonism. The haplotype also co-segregates with a phenotype of essential tremor prevalent in the family. Statistical evidence suggests this region is likely to contain the mutant gene responsible for these alternate phenotypes. We have identified two other families (independent datasets) to support our claim. An Italian kindred which shares chromosome 4p markers that segregate with early-onset Parkinson's disease and Family J (Wisconsin) with early onset Parkinson's diseases that strikingly resembles (clinically, Pathologically and geographically) disease in the Iowa kindred. This latter remains to be genetically and genealogically linked but is likely to be an additional branch. Using these resources, and additional families identified by the Clinical and Linkage Cores, our application is to use positional cloning strategies to identify the mutant gene. This will be achieved by the following techniques: (1) further genetic analysis of families putatively linked to chromosome 4p to refine a minimal haplotype (genetic analyses will include heterogeneity testing, multipoint/haplotype analysis of cross-over data and fine mapping using linkage disequilibrium): (2) rapid cDNA candidates gene sequencing from the linked interval; (3) construction and definition of a physical map (minimal framework contig in YACs, redundant tiling path in PACs, STS, STRP and EST localization); (4) gene identification (EST extention using full length cDNA libraries, exon trapping/cDNA selection, intron/exon genomic organisation, expression analysis) followed by gene sequencing in the search for mutation(s) segregating with early onset parkinsonism. Our subsidiary goals are to determine the importance of this locus in other familiar and idiopathic parkinsonian syndromes, in part through collaboration with the Epidemiology and Genetics of Parkinson's Disease Project (P.I. Walter Rocca, Co-PI Dernetriuus Maraganore).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
3P01NS040256-02S1
Application #
6355621
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2000-08-01
Project End
2001-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
2000
Total Cost
$293,069
Indirect Cost
Name
Mayo Clinic, Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Yue, M; Hinkle, K M; Davies, P et al. (2015) Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis 78:172-95
Sundal, Christina; Fujioka, Shinsuke; Van Gerpen, Jay A et al. (2013) Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 19:869-77
Boeve, Bradley F (2013) Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol 12:469-82
Fujioka, Shinsuke; Rayaprolu, Sruti; Sundal, Christina et al. (2012) A novel de novo pathogenic mutation in the CACNA1A gene. Mov Disord 27:1578-9
Hinkle, Kelly M; Yue, Mei; Behrouz, Bahareh et al. (2012) LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors. Mol Neurodegener 7:25
Graff-Radford, Jonathan; Whitwell, Jennifer L; Trenerry, Max R et al. (2011) Focal brain atrophy in gastric bypass patients with cognitive complaints. J Clin Neurosci 18:1671-6
Puschmann, Andreas; Wszolek, Zbigniew K (2011) Diagnosis and treatment of common forms of tremor. Semin Neurol 31:65-77
Winner, B; Melrose, H L; Zhao, C et al. (2011) Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol Dis 41:706-16
Angeles, Dario C; Gan, Bong-Hwa; Onstead, Luisa et al. (2011) Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum Mutat 32:1390-7
Finch, N; Carrasquillo, M M; Baker, M et al. (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76:467-74

Showing the most recent 10 out of 71 publications